Technical billionaire Elon Musk joined researchers to track COVID-19 infections and antibody levels among 4,300 SpaceX employees for a study published Feb. 15 in Communications about nature.
SpaceX medical directors worked with doctors and researchers to launch an antibody testing program last year. SpaceX employees who volunteered to participate in the study underwent monthly blood tests from mid-April to June 2020, The Wall Street Journal.
Of the 4,300 Spacex volunteers tested, 300 contracted COVID-19. The researchers had enough data on 120 employees to examine their antibody levels and to draw conclusions for the study.
The researchers found that these employees had a level of antibodies that could provide immunity, but “precise levels […] associated with protection against reinfection remain unclear. “
The study also found that antibodies were much lower in those with milder symptoms.
The average age of study participants was 31 and 92 percent were men. The authors said that this could affect their results, as different ages generate different immune responses.
To find out more, click here.
More IT Health Articles:
How health systems can use technology to succeed in value-based care
Cedars-Sinai adds 7 health technology startups to the innovation accelerator
IBM plans to sell IBM Watson Health: 5 notes
© Copyright ASC COMMUNICATIONS 2021. Interested in RELATING or REPRESENTING this content? See our policies by clicking here.